• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态预测总生存期:德国注册处对 979 例尤文肉瘤患者的回顾性分析。

Dynamic prediction of overall survival: a retrospective analysis on 979 patients with Ewing sarcoma from the German registry.

机构信息

Mathematical Institute, Leiden University, Leiden, The Netherlands

Mathematical Institute, Leiden University, Leiden, The Netherlands.

出版信息

BMJ Open. 2020 Oct 12;10(10):e036376. doi: 10.1136/bmjopen-2019-036376.

DOI:10.1136/bmjopen-2019-036376
PMID:33046463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7552850/
Abstract

OBJECTIVES

This study aimed at developing a dynamic prediction model for patients with Ewing sarcoma (ES) to provide predictions at different follow-up times. During follow-up, disease-related information becomes available, which has an impact on a patient's prognosis. Many prediction models include predictors available at baseline and do not consider the evolution of disease over time.

SETTING

In the analysis, 979 patients with ES from the Gesellschaft für Pädiatrische Onkologie und Hämatologie registry, who underwent surgery and treatment between 1999 and 2009, were included.

DESIGN

A dynamic prediction model was developed to predict updated 5-year survival probabilities from different prediction time points during follow-up. Time-dependent variables, such as local recurrence (LR) and distant metastasis (DM), as well as covariates measured at baseline, were included in the model. The time effects of covariates were investigated by using interaction terms between each variable and time.

RESULTS

Developing LR, DM in the lungs (DMp) or extrapulmonary DM (DMo) has a strong effect on the probability of surviving an additional 5 years with HRs and 95% CIs equal to 20.881 (14.365 to 30.353), 6.759 (4.465 to 10.230) and 17.532 (13.210 to 23.268), respectively. The effects of primary tumour location, postoperative radiotherapy (PORT), histological response and disease extent at diagnosis on survival were found to change over time. The HR of PORT versus no PORT at the time of surgery is equal to 0.774 (0.594 to 1.008). One year after surgery, the HR is equal to 1.091 (0.851 to 1.397).

CONCLUSIONS

The time-varying effects of several baseline variables, as well as the strong impact of time-dependent variables, show the importance of including updated information collected during follow-up in the prediction model to provide accurate predictions of survival.

摘要

目的

本研究旨在为尤文肉瘤(ES)患者开发一种动态预测模型,以提供不同随访时间的预测。在随访期间,疾病相关信息会不断出现,这会影响患者的预后。许多预测模型包含基线时可用的预测因子,但并未考虑疾病随时间的演变。

设置

在分析中,纳入了 1999 年至 2009 年期间在德国儿科肿瘤和血液学学会注册中心接受手术和治疗的 979 名 ES 患者。

设计

开发了一种动态预测模型,以预测从随访期间不同预测时间点更新的 5 年生存率。该模型纳入了时间依赖性变量,如局部复发(LR)和远处转移(DM),以及基线时测量的协变量。通过每个变量与时间之间的交互项,研究了协变量的时间效应。

结果

发生 LR、肺部 DM(DMp)或肺外 DM(DMo)对额外存活 5 年的概率有很大影响,HRs 和 95%CI 分别为 20.881(14.365 至 30.353)、6.759(4.465 至 10.230)和 17.532(13.210 至 23.268)。原发肿瘤位置、术后放疗(PORT)、组织学反应和诊断时疾病范围对生存的影响被发现随时间而变化。手术时 PORT 与无 PORT 的 HR 等于 0.774(0.594 至 1.008)。手术后 1 年,HR 等于 1.091(0.851 至 1.397)。

结论

几个基线变量的时变效应,以及时间依赖性变量的强烈影响,表明在预测模型中纳入随访期间收集的更新信息对于提供生存的准确预测非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b8/7552850/43a7519aa5eb/bmjopen-2019-036376f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b8/7552850/a8f8826c2b00/bmjopen-2019-036376f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b8/7552850/656e6b072b7c/bmjopen-2019-036376f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b8/7552850/577a30d696da/bmjopen-2019-036376f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b8/7552850/d57cd9c8dbe1/bmjopen-2019-036376f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b8/7552850/43a7519aa5eb/bmjopen-2019-036376f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b8/7552850/a8f8826c2b00/bmjopen-2019-036376f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b8/7552850/656e6b072b7c/bmjopen-2019-036376f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b8/7552850/577a30d696da/bmjopen-2019-036376f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b8/7552850/d57cd9c8dbe1/bmjopen-2019-036376f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b8/7552850/43a7519aa5eb/bmjopen-2019-036376f05.jpg

相似文献

1
Dynamic prediction of overall survival: a retrospective analysis on 979 patients with Ewing sarcoma from the German registry.动态预测总生存期:德国注册处对 979 例尤文肉瘤患者的回顾性分析。
BMJ Open. 2020 Oct 12;10(10):e036376. doi: 10.1136/bmjopen-2019-036376.
2
Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.尤文肉瘤局部复发和远处转移的个体风险评估:多状态模型:尤文肉瘤的多状态模型。
Pediatr Blood Cancer. 2019 Nov;66(11):e27943. doi: 10.1002/pbc.27943. Epub 2019 Aug 6.
3
Dynamic prediction of overall survival for patients with high-grade extremity soft tissue sarcoma.高级别肢体软组织肉瘤患者总生存期的动态预测
Surg Oncol. 2018 Dec;27(4):695-701. doi: 10.1016/j.suronc.2018.09.003. Epub 2018 Sep 7.
4
Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group.局部标准风险尤文肉瘤能否省略术后放疗?欧洲尤文肉瘤研究组的一项观察性研究。
Eur J Cancer. 2016 Jul;61:128-36. doi: 10.1016/j.ejca.2016.03.075. Epub 2016 May 10.
5
Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model.在一个包含687例四肢高级别软组织肉瘤患者的跨大西洋回顾性队列中,针对局部复发和远处转移的个体化风险评估:一种多状态模型
BMJ Open. 2017 Feb 14;7(2):e012930. doi: 10.1136/bmjopen-2016-012930.
6
Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.骨尤文肉瘤的预后因素:对欧洲多组合作尤文肉瘤研究组975例患者的分析
J Clin Oncol. 2000 Sep;18(17):3108-14. doi: 10.1200/JCO.2000.18.17.3108.
7
What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1.局部控制在尤因肉瘤中的影响:巴西首个协作研究组-EWING1的分析
BMC Cancer. 2017 Jun 15;17(1):420. doi: 10.1186/s12885-017-3391-5.
8
External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma.高级肢体软组织肉瘤患者动态预测模型的外部验证和适应性调整。
J Surg Oncol. 2021 Mar;123(4):1050-1056. doi: 10.1002/jso.26337. Epub 2020 Dec 17.
9
Dynamic Prediction of Overall Survival for Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial Data.骨肉瘤患者总生存期的动态预测:EURAMOS-1 临床试验数据的回顾性分析。
Curr Oncol. 2024 Jun 22;31(7):3630-3642. doi: 10.3390/curroncol31070267.
10
Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology.非转移性骨盆尤文肉瘤:法国儿科肿瘤学会报告
Med Pediatr Oncol. 1999 Nov;33(5):444-9. doi: 10.1002/(sici)1096-911x(199911)33:5<444::aid-mpo2>3.0.co;2-d.

本文引用的文献

1
Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.尤文肉瘤局部复发和远处转移的个体风险评估:多状态模型:尤文肉瘤的多状态模型。
Pediatr Blood Cancer. 2019 Nov;66(11):e27943. doi: 10.1002/pbc.27943. Epub 2019 Aug 6.
2
Dynamic prediction of overall survival for patients with high-grade extremity soft tissue sarcoma.高级别肢体软组织肉瘤患者总生存期的动态预测
Surg Oncol. 2018 Dec;27(4):695-701. doi: 10.1016/j.suronc.2018.09.003. Epub 2018 Sep 7.
3
Risk analysis factors for local recurrence in Ewing's sarcoma: when should adjuvant radiotherapy be administered?
尤因肉瘤局部复发的风险分析因素:辅助放疗应何时进行?
Bone Joint J. 2018 Feb;100-B(2):247-255. doi: 10.1302/0301-620X.100B2.BJJ-2017-0222.R1.
4
Does Radiotherapy after Surgery Affect Outcomes in Ewing's Sarcoma of the Pelvis?骨盆尤因肉瘤术后放疗会影响预后吗?
Indian J Orthop. 2018 Jan-Feb;52(1):73-76. doi: 10.4103/ortho.IJOrtho_388_17.
5
A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC).一种用于高级别肢体软组织肉瘤治疗决策的预测模型:个性化肉瘤护理(PERSARC)。
Eur J Cancer. 2017 Sep;83:313-323. doi: 10.1016/j.ejca.2017.06.032. Epub 2017 Aug 8.
6
Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model.在一个包含687例四肢高级别软组织肉瘤患者的跨大西洋回顾性队列中,针对局部复发和远处转移的个体化风险评估:一种多状态模型
BMJ Open. 2017 Feb 14;7(2):e012930. doi: 10.1136/bmjopen-2016-012930.
7
Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.尤因肉瘤:只有化疗后坏死率达100%的患者才应被归类为反应良好。
Bone Joint J. 2016 Aug;98-B(8):1138-44. doi: 10.1302/0301-620X.98B8.37346.
8
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration.尤因肉瘤:通过合作实现的当前管理和未来方法。
J Clin Oncol. 2015 Sep 20;33(27):3036-46. doi: 10.1200/JCO.2014.59.5256. Epub 2015 Aug 24.
9
Risk of recurrence and survival after relapse in patients with Ewing sarcoma.尤文肉瘤患者复发后的复发风险和生存情况。
Pediatr Blood Cancer. 2011 Oct;57(4):549-53. doi: 10.1002/pbc.23040. Epub 2011 Mar 25.
10
Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry.基于人群癌症登记的尤文肉瘤预后因素分析。
Cancer. 2010 Apr 15;116(8):1964-73. doi: 10.1002/cncr.24937.